composto antagonista do receptor de esfingosina-1-fosfato (s1p), bem como composição farmacêutica e uso do mesmo

This invention provides compounds as shown below, in which either all of Z1-6 are carbon or one of Z1-6 is nitrogen and the rest are carbon, and in which other substituents are defined herein, which are sphingosine-1-phosphate antagonists.

Saved in:
Bibliographic Details
Main Authors KEN CHOW, PHONG X. NGUYEN, TODD M. HEIDELBAUGH
Format Patent
LanguagePortuguese
Published 29.12.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This invention provides compounds as shown below, in which either all of Z1-6 are carbon or one of Z1-6 is nitrogen and the rest are carbon, and in which other substituents are defined herein, which are sphingosine-1-phosphate antagonists.
AbstractList This invention provides compounds as shown below, in which either all of Z1-6 are carbon or one of Z1-6 is nitrogen and the rest are carbon, and in which other substituents are defined herein, which are sphingosine-1-phosphate antagonists.
Author TODD M. HEIDELBAUGH
KEN CHOW
PHONG X. NGUYEN
Author_xml – fullname: KEN CHOW
– fullname: PHONG X. NGUYEN
– fullname: TODD M. HEIDELBAUGH
BookMark eNqNzD0KwkAQhuEttPDvDoOVggFjGlOqKNqJ2IdxMxsW3J0lszmRheA1cjEjegCrr3m_Z6h6nj0NlGh2gSUyoI9YsbcSEUqGmjSFyDWUBCTG-orFekzSxLAY7A4zScN8ATdy0CEMX8m2z_bBYLB2qNtXE61GIGiEP6ojcTxWfYN3oclvR2p62F93x4QCFyQBNXmKxfZyPi3zdJ3l-WaV_RW9AcSiSC0
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID BRPI0918399A2
GroupedDBID EVB
ID FETCH-epo_espacenet_BRPI0918399A23
IEDL.DBID EVB
IngestDate Fri Jul 19 15:57:29 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Portuguese
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_BRPI0918399A23
Notes Application Number: BR2009PI18399
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151229&DB=EPODOC&CC=BR&NR=PI0918399A2
ParticipantIDs epo_espacenet_BRPI0918399A2
PublicationCentury 2000
PublicationDate 20151229
PublicationDateYYYYMMDD 2015-12-29
PublicationDate_xml – month: 12
  year: 2015
  text: 20151229
  day: 29
PublicationDecade 2010
PublicationYear 2015
RelatedCompanies ALLERGAN, INC
RelatedCompanies_xml – name: ALLERGAN, INC
Score 3.0211062
Snippet This invention provides compounds as shown below, in which either all of Z1-6 are carbon or one of Z1-6 is nitrogen and the rest are carbon, and in which other...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title composto antagonista do receptor de esfingosina-1-fosfato (s1p), bem como composição farmacêutica e uso do mesmo
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151229&DB=EPODOC&locale=&CC=BR&NR=PI0918399A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NS8NAEB1KFfWmVbFWZREpCgb7kbTJIYhJWqrQD0qV3sqm3ZUgzQY3xR_kQfBv5I85u7baU29hA4_NhJk3M5l9AbiyG2aFOzY1mrZlGSZmsOhSITOaSK8mMiqnWomp22t0ns2nsTXOwdvqLIzWCf3Q4ojoUVP091TH6-S_iRXo2Up5F0a4JO7bIzcoL6tjRV9YQAee2xr0g75f9n3XG5Z7Q3fwiMSIyYDzgPF6S-XRSmi_9eKpYynJOqe092F7gHBxegC5JC3Arr_69VoBdrrLL954uXQ-eQhSjX8rHQyC1qCvQmneUjITBIMWS7B2JjNGmORIRkJGMcWyjQvJsaom17Ka3NySkM0JggjyixRlX9mnIFx3tbNv3dYmjCykUKhzJufiCC7brZHfMXD3kz9bTbzh2pPWjyEfi5idALF5k2G2VZvW6qGJ74fOaLXCKxyzNepY00YRShuATjfeLcGeMr0a8qg5Z5BP3xfsHKk6DS-0iX8A0pOa7Q
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3bSsNAEB2KivVNq6LWyyJSFAz2kjTJQxCTtrTaG6VK38qm3ZUizQY3xQ_yQfA3-mPOrq32qW8hgSGZZebMmcyeBbhyymaeuw41bMeyDBMrWAypkBk2wquJiMqpVmJqtcv1Z_NxYA1S8LbcC6N1Qj-0OCJG1AjjPdH5Ov5vYlX0bKW8Cyd4S9zX-l4lt2DHCr6QQFd8r9rtVDpBLgg8v5dr97xuA4ERiwH3AfP1po2cUAntV198tS0lXsWU2i5sddFclOxBKk4ykA6WR69lYLu1-OONl4vgk_sg1fi30sEg6A36KpTmLSVjQTBpsRi5MxkzwiRHMBJyElGkbVxIjqyaXMtCfHNLQjYlaESQX0uT-df8UxCuu9rzb93WJozMpFBWp0xOxQFc1qr9oG7g2w__fDX0eytfWjqEjUhE7AiIw22G1VZxVCyFJq4PHdNCnuc5VmvUtUblY8iuMXSy9ukFpOv9VnPYbLSfsrCjlkENfBTdU9hI3mfsDGE7Cc-1u38AODGd2A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=composto+antagonista+do+receptor+de+esfingosina-1-fosfato+%28s1p%29%2C+bem+como+composi%C3%A7%C3%A3o+farmac%C3%AAutica+e+uso+do+mesmo&rft.inventor=KEN+CHOW&rft.inventor=PHONG+X.+NGUYEN&rft.inventor=TODD+M.+HEIDELBAUGH&rft.date=2015-12-29&rft.externalDBID=A2&rft.externalDocID=BRPI0918399A2